Anti-diabetic effects of lemon balm (Melissa officinalis) essential oil on glucose- and lipid-regulating enzymes in type 2 diabetic mice

British Journal of Nutrition

Volumn 104, Issue 2, 2010, Pages 180-188

  Chung, Mi Ja ^a,b   Cho, Sung Yun ^a   Bhuiyan, Muhammad Javidul Haque ^a   Kim, Kyoung Heon ^a   Lee, Sung Joon ^a  

^a Korea University   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

Glucokinase; GLUT4; Hyperglycaemic effects; Lemon balm (Melissa officinalis); Sterol regulatory element binding protein 1c

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; BETA PINENE; BORNEOL; CARVACROL; CARYOPHYLLENE; CITRAL; CITRONELLAL; DODECANE; ESSENTIAL OIL; EUGENOL; FARNESENE; GERMACRENE D; GLUCOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE TRANSPORTER 4; INSULIN; LIMONENE; LINALOOL; MELISSA OFFICINALIS EXTRACT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PLANT MEDICINAL PRODUCT; RNA; SABINENE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TERPINEOL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG; GLUCOSE TRANSPORTER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DILUTION; DOWN REGULATION; DRUG EFFECT; DRUG IDENTIFICATION; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; INSULIN BLOOD LEVEL; MALE; MASS FRAGMENTOGRAPHY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PLANT LEAF; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD; CHEMISTRY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE TOLERANCE TEST; LIPID METABOLISM; MELISSA OFFICINALIS; METABOLISM; PHYTOTHERAPY;

CITRUS LIMON; MELISSA OFFICINALIS; MUS;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOKINASE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; GLUCOSE-6-PHOSPHATASE; INSULIN; LIPID METABOLISM; MELISSA; MICE; OILS, VOLATILE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHYTOTHERAPY; PLANT OILS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 77955296858     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510001765     Document Type: Article

References (45)

1. Taylor SI (1999) Deconstructing type 2 diabetes. Cell 97, 9-12.
2. Chung MJ, Park KW, Kim KH, et al. (2008) Asian plantain (Plantago asiatica) essential oils suppress 3-hydroxy-3-methyl-glutaryl-co-enzyme A reductase expression in vitro and in vivo and show hypocholesterolaemic properties in mice. Br J Nutr 99, 67-75.
3. Chung MJ, Sung NJ, Park CS, et al. (2008) Antioxidative and hypocholesterolemic activities of water-soluble puerarin glyco-sides in HepG2 cells and in C57BL/6J mice. Eur J Pharmacol 578, 159-170.
4. Clegg RJ, Middleton B, Bell GD, et al. (1982) The mechanism of cyclic monoterpene inhibition of hepatic 3-hydroxy-3-methylglutaryl coenzyme-A reductase in vivo in the rat. J Biol Chem 257, 2294-2299.
5. Vonbergmann K, Beck A, Engel C, et al. (1987) Administration of a terpene mixture inhibits cholesterol nucleation in bile from patients with cholesterol gallstones. Klin Wochenschr 65, 458-462.
6. Jung UJ, Lee MK, Park YB, et al. (2006) Effect of citrus flavo-noids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int J Biochem Cell B 38, 1134-1145.
7. Park SA, Choi MS, Kim MJ, et al. (2006) Hypoglycemic and hypolipidemic action of Du-zhong (Eucommia ulmoides Oliver) leaves water extract in C57BL/KsJ-db/db mice. J Ethnopharmacol 107, 412-417.
8. Kietzmann T & Ganjam GK (2005) Glucokinase: old enzyme, new target. Expert Opin Ther Patents 15, 705-713.
9. Hanson RW & Patel YM (1993) Phosphoenolpyruvate carboxy-kinase (Gtp)-the gene and the enzyme. Adv Enzymol Relat Areas Mol Biol 69, 203-281.
10. Nordlie RC, Bode AM & Foster JD (1993) Recent advances in hepatic glucose 6-phosphatase regulation and function. Proc Soc Exp Biol Med 203, 274-285.
11. Pilkis SJ & Granner DK (1992) Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol 54, 885-909.
12. Bogan JS, Mckee AE & Lodish HF (2001) Insulin-responsive compartments containing GLUT4 in 3T3-L1 and CHO cells: regulation by amino acid concentrations. Mol Cell Biol 21, 4785-4806.
13. Suzuki STN, Zhao BP & Yang JZ (2008) Enhanced muscle by myostatin propeptide increases adipose tissue adiponectin, PPAR-a, and PPAR-g expressions. Biochem Biophys Res Commun 369, 767-773.
14. Chung MJ, Kang AY, Park SO, et al. (2007) The effect of essential oils of dietary wormwood (Artemisia princeps), with and without added vitamin E, on oxidative stress and some genes involved in cholesterol metabolism. Food Chem Toxicol 45, 1400-1409.
15. Bisset NG & Wichtl M (1994) Herbal Drugs. Stuttgart: Med-pharm GmbH Scientific Publishers.
16. Lamaison JL & Carnat A (1990) Levels of principal flavonoids in flowers and leaves of Crataegus-Monogyna Jacq and Cratae-gus-Laevigata (Poiret) Dc (Rosaceae). Pharm Acta Helv 65, 315-320.
17. Agata I, Kusakabe H, Hatano T, et al. (1993) Melitric acid-A and acid-B, new trimeric caffeic acid-derivatives from Melissa officinalis. Chem Pharm Bull 41, 1608-1611.
18. Mulkens A & Kapetanidis I (1987) Flavonoids of Melissa officinalis L. leaves (Lamiaceae). Pharm Acta Helv 62, 19-22.
19. Carnat AP, Fraisse D & Lamaison JL (1998) The aromatic and polyphenolic composition of lemon balm (Melissa officinalis L. subsp. officinalis) tea. Pharm Acta Helv 72, 301-305.
20. Berrougui H, Cloutier M, Isabelle M, et al. (2006) Phenolic-extract from argan oil (Argania spinosa L.) inhibits human low-density lipoprotein (LDL) oxidation and enhances cholesterol efflux from human THP-1 macrophages. Atherosclerosis 184, 389-396.
21. de Sousa AC, Alviano DS, Blank AF, et al. (2004) Melissa officinalis L. essential oil: antitumoral and antioxidant activities. J Pharm Pharmacol 56, 677-681.
22. Mimica-Dukic N, Bozin B, Sokovic M, et al. (2004) Antimicrobial and antioxidant activities of Melissa officinalis L. (Lamia-ceae) essential oil. J Agric Food Chem 52, 2485-2489.
23. Singh N & Rajini PS (2004) Free radical scavenging activity of an aqueous extract of potato peel. Food Chem 85, 611-616.
24. Im SS, Kang SY, Kim SY, et al. (2005) Glucose-stimulated upregulation of GLUT2 gene is mediated by sterol response element-binding protein-1c in the hepatocytes. Diabetes 54, 1684-1691.
25. Kamijo Y, Hora K, Nakajima T, et al. (2007) Peroxisome proliferator-activated receptor a protects against glomeru-lonephritis induced by long-term exposure to the plasticizer di-(2-ethylhexyl)phthalate. J Am Soc Nephrol 18, 176-188.
26. Wood IS, Hunter L & Trayhurn P (2003) Expression of class III facilitative glucose transporter genes (GLUT-10 and GLUT-12) in mouse and human adipose tissues. Biochem Biophys Res Commun 308, 43-49.
27. Repa JJ, Turley SD, Quan G, et al. (2005) Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption. J Lipid Res 46, 779-789.
28. Bashan N, Kovsan J, Kachko I, et al. (2009) Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol Rev 89, 27-71.
29. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820.
30. Ceriello A & Testa R (2009) Antioxidant anti-inflammatory treatment in type 2 diabetes. Diabetes Care 32, S232-S236.
31. Decaux JF, Marcillat O, Pichard AL, et al. (1991) Glucose-dependent and glucose-independent effect of insulin on gene expression. J Biol Chem 266, 3432-3438.
32. Fukuda H, Katsurada A & Iritani N (1992) Nutritional and hormonal regulation of messenger RNA levels of lipogenic enzymes in primary cultures of rat hepatocytes. J Biochem (Tokyo) 111, 25-30.
33. Brocklehurst KJ, Payne VA, Davies RA, et al. (2004) Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators. Diabetes 53, 535-541.
34. Dentin R, Pegorier JP, Benhamed F, et al. (2004) Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J Biol Chem 279, 20314-20326.
35. Doiron B, Cuif MH, Kahn A, et al. (1994) Respective roles of glucose, fructose, and insulin in the regulation of the liver-specific pyruvate-kinase gene promoter. J Biol Chem 269, 10213-10216.
36. Ferre T, Riu E, Bosch F, et al. (1996) Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver. FASEB J 10, 1213-1218.
37. 0-flanking sequence. Diabetes 45, 1563-1571.
38. Munoz MC, Barbera A, Dominguez J, et al. (2001) Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats. Diabetes 50, 131-138.
39. Reaven GM (1997) Role of insulin resistance in human disease-syndrome X revisited. Atherosclerosis 134, 3.
40. Davies GF, Khandelwal RL, Wu LY, et al. (2001) Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-g (PPARg)-independent, antioxidant-related mechanism. Biochem Pharmacol 62, 1071-1079.
41. Foretz M, Guichard C, Ferre P, et al. (1999) Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogen-esis-related genes. Proc Natl Acad Sci \USA 96, 12737-12742.
42. Kim SY, Kim HI, Kim TH, et al. (2004) SREBP-1c mediates the insulin-dependent hepatic glucokinase expression. J Biol Chem 279, 30823-30829.
43. Gregori C, Guillet-Deniau I, Girard J, et al. (2006) Insulin regulation of glucokinase gene expression: evidence against a role for sterol regulatory element binding protein 1 in primary hepatocytes. FEBS Lett 580, 410-414.
44. Kim H & Ahn Y (2004) Role of peroxisome proliferator activated receptor-g in the glucose-sensing apparatus of liver and b-cells. Diabetes 53, S60-S65.
45. Kramer D, Shapiro R, Adler A, et al. (2001) Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats. Metabolism 50, 1294-1300.